同時控油又抗氧化的成分,為什麼外用比口服有效?夏天油性肌的科學選擇
成分百科綠茶含有一群叫做「兒茶素(catechins)」的多酚類化合物,其中含量最高、活性最強的是 EGCG(Epigallocatechin gallate),約佔綠茶兒茶素總量的一半以上。它在保養品裡通常標示為 Camellia Sinensis Leaf Extract(綠茶葉萃取)、Green Tea Polyphenols 或直接寫 EGCG。
要注意的是:保養品清單裡的「茶樹(Tea Tree / Melaleuca)」跟綠茶兒茶素完全是兩種不同的東西——茶樹精油走的是抗菌抗痘路線,綠茶兒茶素走的是抗氧化+控油路線,機轉不同,別搞混。
綠茶兒茶素在「對抗紫外線傷害」這件事上有相當紮實的實驗與人體證據——但塗的和吃的結論不一樣,這點很重要。
| 研究 | 方式 | 關鍵發現 | 證據等級 |
|---|---|---|---|
| Katiyar 2001 | 外用(人體皮膚) | 局部塗 EGCG,UV 誘發的過氧化氫下降 68–90%、表皮脂質過氧化下降 41–84% | 高 |
| Elmets 2001 | 外用 RCT | 綠茶多酚劑量依賴性抑制曬後紅斑、減少曬傷細胞與 DNA 損傷 | 高 |
| Heinrich 2011 | 口服 RCT(12 週) | 每日 1402mg 兒茶素,UV 紅斑 12 週降 25%,膚質彈性、保水改善(陽性) | 中 |
| Farrar 2015 | 口服 RCT(12 週) | 1080mg 兒茶素+維C,最小紅斑劑量與發炎介質無顯著差異(陰性) | 中 |
這是綠茶兒茶素最有價值、也最適合台灣夏天的一塊。目前證據強度最高的是 2021 年一篇涵蓋 5 篇 RCT、247 名受試者的統合分析(Kim 2021),結論非常清楚:
| 研究 | 方式 | 結果 |
|---|---|---|
| Yoon 2013 | 外用 EGCG,8 週 split-face RCT | 顯著改善痘痘、耐受性佳;機轉為 AMPK-SREBP-1 降皮脂 + 抑痘菌 |
| Mahmood 2010 | 3% 綠茶乳液,8 週 | Sebumeter 測量皮脂分泌顯著下降 |
| Sharquie 2008 | 2% 茶液 vs 5% 硫酸鋅 | 茶液降發炎痘效果優於硫酸鋅 |
| Lu & Hsu 2016 | 口服 856mg EGCG,4 週 | 僅鼻/口周/下巴改善,總病灶數無顯著差異 |
就算成分本身有效,綠茶保養品還有一個消費者很少被告知的問題——EGCG 又嬌貴又難進皮膚:
Katiyar SK, et al. (2001). Green tea polyphenol treatment to human skin prevents formation of ultraviolet light B-induced pyrimidine dimers in DNA. Carcinogenesis / Clin Cancer Res. PMID: 11181450 外用實驗
Elmets CA, et al. (2001). Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol. PMID: 11209110 外用 RCT
Heinrich U, et al. (2011). Green tea polyphenols provide photoprotection, increase microcirculation, and modulate skin properties of women. J Nutr. PMID: 21525260 口服 RCT
Farrar MD, et al. (2015). A randomized controlled trial of green tea catechins in protection against ultraviolet radiation-induced cutaneous inflammation. Am J Clin Nutr. PMID: 26178731 口服 RCT(陰性)
Di Sotto A, et al. (2022). Antioxidant and Anti-Inflammatory Properties of Green Tea for Skin: A Systematic Review. Nutrients. PMID: 35956325 系統性回顧
Kim S, et al. (2021). The effect of green tea on acne vulgaris: A systematic review and meta-analysis of randomized clinical trials. Phytother Res. PMID: 32812270 統合分析
Yoon JY, et al. (2013). Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes. J Invest Dermatol. PMID: 23096708 外用 RCT
Im M, et al. (2012). Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytes. J Invest Dermatol. PMID: 22763784 機轉研究
Mahmood T, et al. (2010). Outcomes of 3% green tea emulsion on skin sebum production in male volunteers. Bosn J Basic Med Sci. PMID: 20846135 小型臨床
Sharquie KE, et al. (2008). Topical 2% tea lotion in the treatment of acne vulgaris. Saudi Med J. PMID: 19082228 外用 RCT
Lu PH, Hsu CH. (2016). Does supplementation with green tea extract improve acne in post-adolescent women? A randomized, double-blind, placebo-controlled clinical trial. Complement Ther Med. PMID: 27062963 口服 RCT
Hiipakka RA, et al. (2002). Structure-activity relationships for inhibition of human 5α-reductases by polyphenols. Biochem Pharmacol. PMID: 11931850 體外酵素
Scalia S, et al. (2013). Comparative evaluation of the effect of permeation enhancers, lipid nanoparticles and colloidal silica on in vivo human skin penetration and stability of (−)-epigallocatechin-3-gallate. Molecules / Skin Pharmacol Physiol. PMID: 23292326 配方穩定性
Wisuitiprot W, et al. (2011). In vitro human skin permeation and cutaneous metabolism of catechins from green tea extract and green tea extract-loaded chitosan microparticles. Int J Cosmet Sci. PMID: 21790662 滲透研究